Davita Healthcare Partners, Inc. (NYSE:DVA)

CAPS Rating: 4 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar FutureMonkey (84.11) Submitted: 11/30/2012 2:29:14 PM : Underperform Start Price: $53.62 DVA Score: +0.09

Fraud allegations and trial -- bad publicity and potential for increased federal scrutiy.

Featured Broker Partners


Advertisement